Option Care Health's (OPCH) Neutral Rating Reaffirmed at JPMorgan Chase & Co.

Key Points

• JPMorgan reaffirmed its “neutral” rating on Option Care Health and maintained a $33.00 price target, implying approximately 6.33% upside from the previous close.
• Analyst sentiment remains cautious: the consensus rating is “Hold,” based on three Buy ratings and twelve Holds, with an average price target of $29.70.
• CD&R and McKesson have agreed to acquire Option Care Health for $32.05 per share in cash, valuing the company at roughly $5.8 billion; the pending deal is now the primary driver of the stock and leaves a spread reflecting completion and timing risks.

Option Care Health (NASDAQ:OPCH - Get Free Report)'s stock had its "neutral" rating reaffirmed by stock analysts at JPMorgan Chase & Co. in a report issued on Wednesday, Benzinga reports. They presently have a $33.00 price target on the stock. JPMorgan Chase & Co.'s target price would indicate a potential upside of 6.33% from the company's previous close.

Several other equities analysts have also issued reports on OPCH. Weiss Ratings raised Option Care Health from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Friday, September 11th. Truist Financial set a $32.05 price objective on Option Care Health in a report on Wednesday. Stephens restated an "equal weight" rating and set a $24.00 target price (down from $30.00) on shares of Option Care Health in a research report on Friday, July 17th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a $24.00 target price (down from $26.00) on shares of Option Care Health in a research note on Thursday, July 30th. Finally, Zacks Research upgraded shares of Option Care Health from a "strong sell" rating to a "hold" rating in a research report on Monday, July 6th. Three research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $29.70.

Option Care Health Price Performance

Shares of Option Care Health stock traded up $0.04 during midday trading on Wednesday, reaching $31.04. The company had a trading volume of 11,424,895 shares, compared to its average volume of 2,817,709. The company has a current ratio of 1.47, a quick ratio of 0.98 and a debt-to-equity ratio of 0.91. The stock has a fifty day simple moving average of $23.78 and a 200 day simple moving average of $23.55. Option Care Health has a 1-year low of $18.01 and a 1-year high of $36.80. The company has a market capitalization of $4.65 billion, a price-to-earnings ratio of 23.33, a price-to-earnings-growth ratio of 1.35 and a beta of 0.58.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.02. The firm had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.42 billion. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The business's revenue for the quarter was up 1.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.41 EPS. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. As a group, equities research analysts forecast that Option Care Health will post 1.7 earnings per share for the current year.

Hedge Funds Weigh In On Option Care Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Harbor Investment Advisory LLC bought a new stake in shares of Option Care Health in the 2nd quarter valued at about $48,000. Nykredit A S bought a new position in Option Care Health during the 2nd quarter worth approximately $56,000. Public Employees Retirement System of Ohio acquired a new position in Option Care Health during the second quarter valued at approximately $66,000. KBC Group NV grew its holdings in Option Care Health by 22.1% during the first quarter. KBC Group NV now owns 5,453 shares of the company's stock valued at $147,000 after purchasing an additional 988 shares during the period. Finally, Summitry LLC bought a new stake in Option Care Health in the first quarter valued at approximately $200,000. Institutional investors own 98.05% of the company's stock.

Key Headlines Impacting Option Care Health

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: CD&R and McKesson agreed to acquire Option Care Health for $32.05 per share in cash, representing a 37% premium to the unaffected price and an estimated enterprise value of approximately $5.8 billion. The transaction is the primary catalyst behind the stock’s surge and moves Option Care toward becoming a private company. CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
• Positive Sentiment: The stock is trading near, but below, the $32.05 offer price. The remaining spread reflects investors’ assessment of deal-completion risk and potential timing, while the all-cash consideration provides a clearly defined valuation. Option Care Stock Trades Below McKesson’s Deal Price
• Neutral Sentiment: Citizens JMP and Barrington Research both reaffirmed “Market Perform” ratings. These actions do not materially change the investment outlook because the stock is now primarily driven by the pending acquisition rather than standalone earnings prospects. Option Care Health Stock Rating Reaffirmed as Market Perform
• Neutral Sentiment: Unusually heavy call-option activity and trading volume indicate strong investor interest following the buyout announcement, but these signals do not guarantee additional upside beyond the offer price.
• Negative Sentiment: Several shareholder-rights law firms are investigating whether the $32.05 price fairly values Option Care and whether company insiders received benefits unavailable to ordinary shareholders. Such reviews could create legal or timing uncertainty, although no challenge to the transaction has been reported. Ademi LLP Investigates Option Care Health Buyout

Option Care Health Company Profile

Option Care Health, Inc NASDAQ: OPCH is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients' homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.